Resources
Filter by
The most recently added documents are listed below. To narrow down the results into the key area you are interested in, select the relevant term and press search. You can narrow the results further by selecting more terms. Untick a selected box to remove that filter or click reset to start over.
This document presents (i) the principles important to the design of trachoma prevalence surveys conducted after interventions intended to eliminate the disease as a public health problem, and (ii) WHO recommendations for their implementation.
This article looks at the contribution of Helen Keller International and its work to build the capacity of Ministries of Health to conduct community mobilization, mass drug administration campaigns, morbidity management, monitoring and evaluation for neglected tropical diseases.
This study explores the relationship between TF and PCR throughout an elimination program and a sero-catalytic model to evaluate the utility of two cross-sectional sero-surveys for estimating sero-conversion rates.
This study assessed several methods for identifying a core group for trachoma, assuming varying degrees of knowledge about the transmission process.
This systematic review synthesises evidence on the emergence of antimicrobial resistance after mass azithromycin distribution.
This systematic review synthesises evidence on the emergence of antimicrobial resistance after mass azithromycin distribution.
In a trachoma hyperendemic region, a TF prevalence <5% was successfully maintained in five districts for ≥2 years after stopping MDA. MDA is still not warranted for these districts, however, the S, F and E components of the SAFE strategy should continue.
GET2020 data for Trachoma Free Africa countries
This study investigated the impact of two round of mass drug administration on trachoma prevalence in Plateau and Nasarawa States of Nigeria.